Büchler, M <br/><br/>
Sirolimus versus cyclosporine in kidney recipients receiving thymoglobulin, mycophenolate mofetil and a 6-month course of steroids.  [electronic resource] 

 -  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons  Nov 2007 
 - 2522-31 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1600-6135 
<br/><br/><label>Standard No.: </label>10.1111/j.1600-6143.2007.01976.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenal Cortex Hormones--therapeutic use<br/>Adult<br/>Antibodies, Monoclonal--therapeutic use<br/>Antilymphocyte Serum<br/>Cyclosporine--therapeutic use<br/>Female<br/>Glomerular Filtration Rate<br/>Graft Survival<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Kidney Transplantation--immunology<br/>Male<br/>Middle Aged<br/>Mycophenolic Acid--analogs & derivatives<br/>Sirolimus--therapeutic use<br/>Survival Analysis